allergic (delayed and persistent lesions) and nonallergic (recurrent acute prurigo) forms. We propose a pragmatic classification based on seasonality (Fig 1) . 9 With this classification in mind, the causal agent is more easily identified, unnecessary allergy tests are avoided, and specific treatment (eg, specific immunotherapy) can be proposed in the future.
IL6 polymorphisms modify the effects of smoking on the risk of adult asthma
To the Editor:
The cytokine IL-6 can participate in asthma pathogenesis, 1 and it is produced as a response to different stimuli, including tobacco smoke. 2 Recently, we reported an association between the IL6 single nucleotide polymorphism (SNP) rs1800797 and adult-onset asthma.
3 IL6 SNP rs1800795 and other SNPs (including rs1800797) in close linkage disequilibrium (LD) with it seem to associate with asthma, especially in adults, 4 but divergent findings exist also (see the Methods section in this article's Online Repository at www.jacionline.org for details).
We hypothesized that unidentified gene-environment interactions could explain some of these differences in findings. Tobacco smoking is an obvious candidate because it is common among adults but rare among children. We have shown previously that smoking is a determinant of asthma, 5 and an interaction between tobacco smoke and IL6 SNPs on conditions other than asthma has been reported. 6 Our study population was the Finnish Environment and Asthma Study (FEAS), a population-based, incident, case-control study of adult-onset asthma including 521 patients with newly diagnosed asthma and 932 control subjects. For replication, we used the Cold, Infections and Asthma in Soldiers (CIAS) study, a case-control study of Finnish military conscripts including 224 patients with previously diagnosed asthma and 668 control subjects, all of whom were men.
A total of 467 cases and 613 control subjects in FEAS, and 225 cases and 642 control subjects in the CIAS study were genotyped. We estimated the relations between rs1800797 and adult-onset asthma in FEAS, stratifying by smoking status. In the CIAS study we analyzed association for rs1800795, which is in high LD with rs1800797. Of the tested genetic models, the recessive model was found to fit best. We performed meta-analyses of effect estimates from the adjusted recessive models. For cross-reference of the association results, we imputed rs1800795 in FEAS and rs1800797 in the CIAS study and analyzed their association with asthma. We tested for additive and multiplicative interactions between the IL6 SNPs and smoking (see the Methods section in this article's Online Repository for details).
Characteristics of our study populations are shown in the Methods section and Table E1 in this article's Online Repository at www.jacionline.org. In FEAS rs1800797 associated with incident asthma among those with any smoking exposure (Fig 1, A and B) , and a similar but weaker association was found between rs1800795 and prevalent asthma in the CIAS study (Fig 1, C and D) . No association was seen among the never smokers (Fig 1, A-D) . In a meta-analysis the GG genotype of either polymorphism associated with an increased risk of asthma among those who reported any smoking exposure (Fig 1, E , see the Methods section in this article's Online Repository). More detailed categorization by smoking status revealed association among the former and current smokers, as well as among the regular smokers (Fig 1 and see Table E2 in this article's Online Repository at www.jacionline.org). No sex-based difference in the effect of genotype was observed in FEAS (data not shown). The imputed genotypes showed similar association patterns as the directly genotyped SNPs (see the Methods section in this article's Online Repository and Table E2 ).
In FEAS an additive-level interaction was seen between the rs1800797 GG genotype and any smoking (Fig 2, C) , and weaker interactions were observed for former and current smoking (Fig 2, F) . Slightly stronger interaction of rs1800797 with 200 or more cigarette years smoked than with 1 to 199 cigarette years smoked was observed among the any smoking (Fig 2, I ) and previous smoking categories (Fig 2, L) . In the CIAS study the rs1800795 GG genotype showed a slightly increased but statistically nonsignificant joint effect in relation to any smoking and current smoking (see Table E3 in this article's Online Repository at www.jacionline.org), whereas in FEAS interaction was observed also at a multiplicative level (see Table E4 in this article's Online Repository at www.jacionline.org).
We show in 2 independent Finnish study populations that the IL6 SNPs rs1800797 and rs1800795 modify the effect of tobacco smoke exposure on asthma risk. The GG genotype of either polymorphism was found to associate with an increased risk of asthma among those who had some tobacco smoke exposure but not among never smokers. The results were FIG 1. Association of IL6 polymorphisms with asthma under the recessive model and according to smoking exposure. The effect of the GG genotype when compared with the effect of the AA/GA (FEAS) or CC/GC (CIAS) genotypes in each exposure stratum is shown. A and B, Unadjusted (Fig 1, A) and adjusted (Fig 1,  B) associations of rs1800797 with asthma in FEAS. C and D, Unadjusted (Fig 1, C) and adjusted (Fig 1, D) associations of rs1800795 with asthma in the CIAS study. E, Random-effects meta-analysis of precalculated adjusted effect estimates. Fig 1, B, D , and E, show values adjusted for age, sex, and education in FEAS and for age and education in the CIAS study. OR, Odds ratio. Squares, estimates for FEAS; circles, estimates for the CIAS study; rhombi, meta-analysis estimates.
FIG 2.
Additive level interaction between the IL6 polymorphism rs1800797 and smoking status or cigarette years in FEAS under the recessive model. A-C, rs1800797 genotype and smoking categorized as never smokers and any smoking exposure. D-F, rs1800797 genotype and smoking categorized as never smokers, former smokers, and current smokers. G-I, rs1800797 genotype and cigarette years in never smokers and those with any smoking exposure. J-L, rs1800797 genotype and cigarette years in never smokers and former smokers. M-O, rs1800797 genotype and cigarette years in never smokers and current smokers. Fig 2, B, C, E, F, H, I, K, L, N, and O, indicate analysis adjusted for age, sex, and education. The reference category is defined by having AA/GA and being a never smoker. A subject in the reference category has AA/GA and is a never smoker. CIGY, Cigarette years; OR, odds ratio; SMK, smoker. *P < .05. similar in both study populations and strengthened in the metaanalysis of the study-specific effect estimate, as well as in the analysis of imputed genotypes. Some differences in results between the FEAS and the CIAS study populations were observed (see the Results section in this article's Online Repository at www.jacionline.org for details and validity issues).
No previous study has reported interaction between IL6 polymorphisms and smoking in relation to asthma. However, our results gain plausibility from previous studies on interaction between IL6 and tobacco smoke on several other health outcomes, including coronary artery disease. 6 It is likely that the same regulatory mechanisms play a role in several diseases; for example, cardiovascular diseases and allergic disorders have been linked to each other. 7 Most of the studies that have reported an interaction between smoking and rs1800795 or rs1800797 found that the C or A allele 6 carried the risk, whereas in our observation an increased risk was associated with the GG genotype. However, it is plausible that a genotype might predispose to one disease and be protective for another because the disease mechanisms are likely to be different. Also, the IL-6 response to stimuli can vary by cell type, and thus response in circulating levels of IL-6 can differ from that seen in locally produced IL-6. Supporting our findings, a recent meta-analysis reported a protective effect of the rs1800795 CC genotype for asthma in white subjects and adults (see the Discussion section in this article's Online Repository at www.jacionline.org). 4 All of the studies reporting gene-environment interaction between IL6 and tobacco smoke have been candidate gene studies. Two genome-wide gene-smoking interaction studies have investigated asthma, but they found only suggestive associations not including IL6. 8, 9 However, in genome-wide studies some true-positive findings might be rejected because of the rigorous significance level.
In conclusion, carrying the GG genotype in either rs1800797, rs1800795, or both can increase susceptibility to the adverse effects of smoking on the risk of asthma. This could explain some of the controversies observed in previous studies regarding IL6 polymorphisms and asthma. Clinical relevance of sensitization to hydrolyzed wheat protein in wheat-sensitized subjects
To the Editor:
Wheat is the source of allergens for different type I allergies: classical food allergy; wheat-dependent, exercise-induced anaphylaxis (WDEIA); and occupational allergic rhinoconjunctivitis or asthma. Hydrolyzed wheat proteins (HWPs) are used in a variety of products, ranging from food to cosmetics. Wheat hydrolysates are produced through either a chemical process of heating gluten at acidic pH or through enzymatic treatment. This provides the food industry a wider range of use because the hydrolyzed product is soluble in water. Although the general opinion is that hydrolysis reduces allergenicity, there are limited numbers of reported cases and studies on sensitization and allergy to HWPs. [2] [3] [4] [5] [6] [7] The aim of this study was to characterize patients with a case history of anaphylaxis related to ingestion of a product containing HWPs and to investigate patients with other phenotypes of wheat allergy for cosensitization to HWPs.
Details of the methods can be found in the Methods section in this article's Online Repository at www.jacionline.org. In this study we looked at a single hydrolyzed wheat product, Meripro 711 (Tate and Lyle, Syral, Aalst, Belgium). In brief, we assessed 9 patients with a history of anaphylaxis to HWPs, and for comparison, we determined the frequency and assessed the potential relevance of HWP sensitization in an existing cohort of 45 patients with suspicion of wheat-induced anaphylaxis (WIA) and WDEIA (Fig 1) .
All patients were examined with a detailed case history, skin prick tests (SPTs), and specific IgE (sIgE) and basophil histamine release (BaHR) measurements, followed by an open food challenge with cake mix containing HWPs to the extent to which it was available because the product (AMO Letbagt; Lantm€ annen Cerealia A/S, Stockholm, Sweden) was withdrawn from the market after the first public reports on allergic reactions. Patients with WIA and WDEIA were challenged with wheat or gluten (with or without exercise).
METHODS

Review of previous studies assessing IL6 polymorphisms and asthma
Recently, we reported an association between the IL6 SNP rs1800797 and adult-onset asthma.
E1 Based on previous studies, rs1800795 and other IL6 SNPs (including rs1800797) in close LD with it seem to associate with asthma in adults E2-E5 but not in children. E6 However, one study found no association in adults, E7 whereas 2 reported association in children. E8,E9 Furthermore, among the studies using populations composed of children and adults, 2 found an association, E10,E11 and 1 did not. E12 Regarding the effect of tobacco smoke, of the previous studies that included adults, most did not take smoking into account, E2-E5,E11,E12 1 excluded subjects with a history of smoking, E10 and 1 excluded those with a history of 10 pack years or more. E7 There has also been a discrepancy about which alleles are risk-associated ones, but this can be explained by different LD patterns in populations of different ethnicity, as demonstrated by Ivanova et al E13 and others.
Study populations
FEAS is a population-based, incident, case-control study of adult-onset asthma, as described in detail elsewhere. E14 In short, we recruited systematically all new adult (21-63 years of age) patients with asthma during 1997-2000 in the Pirkanmaa Hospital District, South Finland. The response rate among cases was 86%, and a total of 521 cases participated. Control subjects were drawn randomly from the source population, and general eligibility criteria (living in the Pirkanmaa area; age, 21-63 years) were applied. A total of 1016 control subjects participated (response rate, 80%). After excluding those with previous or current asthma (n 5 76), those older than 63 years (n 5 6), and those with incomplete questionnaires (n 5 2), our study population included 932 control subjects.
The CIAS study is a case-control study conducted among Finnish military conscripts aged 17.4 to 29.6 years in the Kainuu Brigade, Kajaani, Northern Finland, during 2004-2006; they have been described in detail elsewhere.
E15
The participants belonged to 2 intake groups: one entered service in July 2004 and the other in January 2005. Total numbers of recruits in the intake groups were 1836 and 1861, with response rates of 82% and 75%, respectively. All men with a previous diagnosis of asthma, as well as randomly selected control subjects without asthma, were recruited. Forty-five men were discharged from the service and the study population because of medical problems other than asthma. Altogether, 224 men with asthma and 668 control subjects participated.
The FEAS protocol was approved by the ethics committees of the Finnish Institute of Occupational Health, Tampere University Hospital, and the Oulu University Hospital District, and the CIAS study protocol was approved by the ethics committees of the Kainuu Central Hospital and the Oulu University Hospital District. Informed consent was obtained from all participants in both studies.
Diagnosis of asthma and lung function measurements
In FEAS the diagnostic criteria for asthma followed the Finnish National Asthma Guidelines. E16 The criteria were as follows: (1) occurrence of at least 1 asthma-like symptom and (2) demonstration of significant reversibility in patients with airways obstruction in lung function investigations.
E14
Spirometry and bronchodilatation test results were recorded with a pneumotachograph spirometer by using a disposable flow transducer (Medikro 905; Medikro, Kuopio, Finland), according to the standards of the American Thoracic Society. E17 In the CIAS study information on asthma was obtained with a self-administered questionnaire. Asthma was defined based on answering ''yes'' to the questions ''Have you ever had asthma?'' and ''Has your asthma been diagnosed by a physician?'' Data on military service-related health and call-up examinations were used to confirm the participant's own opinion. In Finland military recruits are first examined by a local practitioner, and then, a re-examination is performed at call-up by an army physician.
Exposure assessment
In both studies smoking was assessed based on a self-administered questionnaire the participants filled in at the beginning of the study. E15,E18 Smoking was defined as follows: a regular smoker was defined as smoking at least 1 cigarette or cigar a day or 25 g of pipe tobacco a month (FEAS) or smoking daily (CIAS study); an occasional smoker was defined as less than 1 cigarette a day or 25 g of pipe tobacco a month (FEAS) or smoking less frequently than daily (the CIAS study); a current smoker was defined as a regular and occasional smoker; a former smoker was defined as one who had had quit smoking; and any smoking was defined as current and former smokers. In FEAS cumulative lifetime cigarette years were calculated as follows:
Average smoking rateðcigarettes=cigars=pipes per dayÞ3 Duration of smoking:
DNA extraction, SNP selection, and genotyping
In FEAS a DNA sample was available for 467 cases and 613 control subjects. DNA extraction, SNP selection, and genotyping have been described previously.
E1 In short, DNAwas extracted from EDTA blood samples stored at 2708C at BioSer Oulu (Department of Biology, University of Oulu, Finland). Six tagging SNPs, namely rs2069824, rs2069827, rs1800797 (2597 A/G), rs1524107, rs2069840, and rs2069861, in the IL6 gene were genotyped at the FIMM Technology Centre (University of Helsinki) by using Illumina's GoldenGate Genotyping Assay, the iScan System, and with standard reagents and protocols provided by Illumina (San Diego, Calif). The detailed association analysis of these SNPs with adult-onset asthma is described in our previous study, in which rs1800797 was found to associate with adult-onset asthma.
E1
In the CIAS study a DNA sample was available for 225 cases and 642 control subjects. DNA was extracted from isolated and homogenized leukocytes. E19 Tagging SNPs or potentially functional SNPs in genes important for immune system and infections were genotyped at the Mutation Analysis Facility (Karolinska Institute, Stockholm, Sweden). Genotyping was performed by using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (Sequenom GmbH, San Diego, Calif).
Assessment of serum highly sensitive C-reactive protein
In the CIAS study serum highly sensitive C-reactive protein (hsCRP) levels were available from both the beginning and end of military service. hsCRP levels were measured with an Immunoenzymometric Assay (Medix Biochemica, Kauniainen, Finland) from the blood samples, according to the manufacturer's instructions. The range of the assay was 0.3 to 30 mg/L, and the sensitivity was 0.08 mg/L.
Statistical analyses
Our goal was to further elaborate our previous finding of a significant association between IL6 SNP rs1800797 and adult-onset asthma in FEAS.
E1
We first analyzed the association of rs1800797 with asthma in FEAS stratified by smoking status. To reproduce our findings, we analyzed association of IL6 with asthma in the CIAS study. In the CIAS study the previously genotyped SNPs did not include rs1800797, and because of this, rs1800795 was selected instead for the replication analysis. This SNP is in high LD with rs1800797; for example, in the Finnish 1000 Genomes Project sample the r 2 value was 0.921. E20 Both SNPs are located in the 59 (promoter) area of the IL6 gene, and both have been reported as functional in the literature E21,E22 and in databases. E23,E24 Thus the SNPs are proxies for each other, and both can also contribute to causal mechanisms, leading to asthma. Log-additive, genotypic, dominant, and recessive genetic models were tested, applying logistic regression analysis. No correction for multiple testing was done because the aim was to find the best fitting model for the association of 1 SNP in each data and under 1 interaction hypothesis. Goodness of fit of the different unadjusted models was tested by using the Akaike information criterion.
Because the CIAS study population was composed entirely of male subjects, we also studied the potential effect of sex on our results by analyzing the associations in FEAS for men and women separately. Associations were analyzed by applying PLINK (version 1.07), E25 and goodness of fit was tested with the SAS statistical package (version 9.3; SAS Institute, Cary, NC).
To combine the information from FEAS and the CIAS study, we performed a meta-analysis of the precalculated effect estimates from the adjusted recessive models by using STATA 13.0 (StataCorp, College Station, Tex), applying the ''Metan'' command and a random-effects model.
Imputation of genotypes on FEAS and CIAS study data was performed with Impute software (version 2.3.2; Genetics Software Suite, University of Oxford, Oxford, United Kingdom). All of the successfully genotyped SNPs in the IL6 gene area were used as input information for the imputation. In FEAS this included the SNPs rs2069824, rs2069827, rs1800797, rs1524107, rs2069840, and rs2069861, and in the CIAS study this included the SNPs rs1800795, rs1474347, rs1554606, and rs2069845. We used the 1000 Genomes Project phase 3 data available at the IMPUTE2 Web site (https:// mathgen.stats.ox.ac.uk/impute/impute_v2.html# reference) as a reference panel. Imputation was performed on the IL6 gene and the nearby area (ie, chromosome 7) between base pair locations 22,763,000 and 22,790,000 (National Center for Biotechnology Information build 37), with a default setting of the effective population size (-Ne) of 20,000. We used SNPTEST software (version 2.5.2; Genetics Software Suite, University of Oxford) for association analysis of imputed data, applying the frequentist test with multiple Newton-Raphson iterations (method -ml). Association tests were performed for the SNPs rs1800797 and rs1800795 under a recessive genetic model.
Gene-environment interaction at the additive level was studied by estimating the independent and joint effects of the SNPs (recessive model) and smoking on the risk of asthma and by comparing the risk of asthma in the different determinant categories with the reference category constituting ''reference genotype and never smoker.'' Estimates of the independent and joint effects were derived from the same logistic regression model. Models were first adjusted for age, sex, and education as a proxy for socioeconomic status (in FEAS) or for age and education (in the CIAS study). Age, sex, and socioeconomic status are known to associate with the risk of asthma and smoking habits. In addition, especially age and sex can affect manifestation of the genetic factors. In FEAS we also performed additional adjustment for having indoor pets, presence of dampness, and/or mold at home or work; recent (past 12 months) and lifetime cumulative SHS exposure; and maternal smoking during pregnancy as potential confounders.
We present the results as the excess relative risk (ERR) for the independent and joint effects for the categories of genotype (A) and smoking (B). The departure from additivity of relative risks is quantified by the relative excess risk due to interaction (RERI) as follows:
We estimated the 95% CIs for RERI by applying the method of variance estimates recovery. E26 For RERI, the null value corresponds to a statistical significance level with a P value of .05. In FEAS we also tested for interaction on the multiplicative level. Interaction variables were calculated based on the original variables as follows:
Interaction5Genotype 3 Smoking status:
Logistic regression analyses with and without the interaction variable were performed. For interaction analyses, we used the SAS statistical package, version 9.3.
In the CIAS study we demonstrated previously an association between the rs1800795 C allele and CC genotype and increased levels of serum hsCRP.
E27
Because IL-6 induces CRP production, the IL6 SNPs affecting IL-6 levels can also affect CRP levels. Of the CIAS study participants with a genotyping result, hsCRP measurements were available for 864 participants from the beginning of service and for 773 participants from the end of service. Here we reanalyzed the association of rs1800795 with serum hsCRP levels in the CIAS study under a recessive model and stratified by smoking exposure for the cases and control subjects separately. Because of several samples with levels close to the lower detection limit of the assay, we categorized hsCRP levels as normal and increased levels according to the third quartile of the measurements in each time point. All of the adjusted analyses took into account age, education, and intake group (July 2004 or January 2005 . In addition, we adjusted analyses of the end of service hsCRP measurement for the duration of service (6, 9, or 12 months). The intake group and duration of service were taken into account because of the possible seasonal variation in hsCRP levels. Association analyses were performed by applying PLINK, version 1.07. E25 
RESULTS
Characteristics of our study populations are shown in Table E1 . In FEAS there were more women among the asthmatic patients than among the control subjects, and the asthmatic patients were younger and less educated. Both of the SNPs, rs1800797 in FEAS and rs1800795 in the CIAS study, followed Hardy-Weinberg equilibrium with a P value of greater than .05. The allele frequencies of the SNPs were similar: among control subjects, the frequency of the rs1800797 G allele was 0.467 in FEAS, and the frequency of the rs1800795 G allele was 0.472 in the CIAS study (2-sided Pearson x 2 test for the allele frequency distributions: P 5 .82).
Of the tested genetic models, the recessive model was found to be the best fit in most of the analyses. In FEAS an association was detectable under all but the dominant model, whereas in the CIAS study an association was detected only under the recessive model. Imputation certainty of the SNP rs1800795 in FEAS and that of the SNP rs1800797 in the CIAS study was good, with information metrics of 0.973 and 0.938, respectively. Information typically has values of between 0 and 1, with values near 1 indicating high imputation certainty. Also, the concordance and correlation between the input and imputed genotypes for the SNP rs1800797 in FEAS and rs1800795 in the CIAS study were good, with concordance of 0.998 and an r 2 value of 0.978 for rs1800797 and concordance of 0.993 and an r 2 value of 0.991 for rs1800795. The associations observed for the imputed SNPs (Table E2) were highly similar to the findings based on analyzing 2 separate but high pairwise LD SNPs (Fig 1 and Table E2 ).
In the CIAS study, among the control subjects, the rs1800795 genotype GG associated with a decreased risk of having hsCRP levels in the third quartile or greater in the whole group and in the any smoking and current smoking categories both at the beginning and end of service (Table E5) . No association was seen among the cases (data not shown).
DISCUSSION
Validity issues
The participants of the CIAS study represent ordinary healthy young Finnish men. The conscripts of the Kainuu Brigade mainly come from the central area of Finland. In Finland military service is mandatory, and all men aged 18 to 19 years are called up. Chronic illnesses are generally a reason for exemption, but young men with asthma under good control can be enrolled. The definition of physician-diagnosed asthma was based on responses to the questionnaire, but the diagnosis was confirmed with data from previous medical appointments and from the first examination at service. No pulmonary function testing, except for peak expiratory flow measurements, was done because all the asthmatic participants had controlled asthma. The CIAS study did not include men with severe or uncontrolled asthma because they were exempted during the clinical examinations or were discharged during the first 2 weeks of service. Limitations of the CIAS study population regarding a gene-smoking interaction study include the prevalent setting of cases, lack of more severe asthma cases, and young age and thus likely a relatively short duration of the smoking exposure of the participants.
Exposure assessment was based on questionnaires. In FEAS the study was introduced to the participants as an investigation of environmental factors in general, and in the CIAS study the primary study focused on experiences of cold and infections during the service, with no special focus on smoking mentioned in either study. These approaches reduced information bias in participants' reports. Any random misclassification of exposure would lead to underestimation of the effects. Lack of a true replication (ie, direct genotyping) of the 2 SNPs in the 2 study populations is a limitation in our study and could be reflected in the slightly different association and interaction patterns observed in the studies.
The response rates in both of our studies were high, which reduces the likelihood of selection bias. Sample sizes were based on the primary objectives of the studies, which provided a relatively good power for detecting effects of common polymorphisms and gene-environment interactions between common variants and exposures, as shown by the relatively narrow 95% CIs of, for example, any smoking category (Figs 1  and 2 ). However, some of the smoking subcategories were small, and in those our study lacks power.
Differences in associations and gene-environment interactions between FEAS and the CIAS study
The consistently stronger associations observed in FEAS than in the CIAS study could be due to a sex effect because the CIAS study included only men. However, analysis of the sexes separately in FEAS did not support this theory. There can also be a true difference between the SNPs rs1800797 and rs1800795 because the LD between these two might not be complete. For example, in the 1000 Genomes Project's populations the pairwise r 2 values of these SNPs among the Finns was 0.921. E20 In addition, both SNPs have been reported as functional in the literature E21,E22,E28,E29 and in databases E23,E24 and thus could have their own effect on IL-6 production. Yet the results from association analyses of the imputed genotypes do not support this option because they were highly similar to the associations observed for the directly genotyped SNPs. The difference between the 2 studies might also be due to the different types of cases: in FEAS the cases are incident, included only adult-onset asthma, and represent a population-based sample of a certain geographic area, whereas in the CIAS study the cases are prevalent and the age of asthma onset is not known. If the association is stronger in adulthood, as suggested by the recent meta-analysis, E4 FEAS would be expected to detect it better than the CIAS study. Also, the gene-environment interaction between IL6 SNPs and smoking would be expected to be better captured by FEAS, in which the exposure is known to precede the outcome.
In the CIAS study some of the participants are likely to have had asthma in childhood or in their teenage years and then started smoking at a later age. On the other hand, patients with asthma symptoms or asthma in childhood would be expected to avoid smoking later in life. Such selection is also the most plausible explanation for the protective main effect of smoking on the risk of asthma that was observed in the CIAS study; that is, only those subjects who have not had symptoms (as the first sign of asthma) as a consequence of smoking have continued to smoke.
This phenomenon of selection away from smoking is to some degree seen also in FEAS, in which the gene-environment interaction was stronger with former smoking than current smoking. We have reported previously a similar phenomenon from FEAS concerning the independent effects of smoking on the risk of developing asthma: the effect estimate was somewhat higher for former smokers (odds ratio, 1.49) than for current smokers (odds ratio, 1.33). E18 Those subjects who are the most susceptible and thus have asthma symptoms related to a smaller exposure are more likely to quit smoking, reduce smoking, or smoke less. The latter 2 behavioral reactions probably explain the observation that in FEAS, among current smokers, the interaction was slightly stronger with the lower exposure level of cigarette years smoked.
Finally, the study population in the CIAS study was on average much younger than that in FEAS, suggesting a clearly shorter average duration of smoking exposure, and as a consequence, a smaller effect related to it in the CIAS study compared with FEAS. This could be reflected especially in the differing findings regarding the effect of former smoking in the 2 studies, where the effect observed was clearly stronger in FEAS.
Association of rs1800797 with serum hsCRP levels
Our finding that the rs1800795 genotype GG associates with a decreased risk of increased hsCRP levels in CIAS control subjects among any smokers and current smokers provides evidence of a functional effect of the polymorphism.
Previous studies assessing interaction between IL6 polymorphisms and tobacco smoke Supporting our findings of interaction between IL6 rs1800797 and rs1800795 and tobacco smoking on asthma are several previous studies that reported interaction on health conditions other than asthma. Interaction between the IL6 2174 G/C (ie, rs1800795) SNP and smoking has been reported to increase the risk of, for example, myocardial infarction, E30 coronary artery disease, E31,E32 and bladder cancer. E33 In addition, interaction between rs1800795 and smoking on levels of inflammatory markers E34 has been reported. On the other hand, other studies have not been able to show interactions between rs1800795 and smoking in relation to coronary heart disease, E35 myocardial infarction, E36 or inflammatory markers. E37 In relation to rs1800797, an increased risk of lung cancer among the never smoking A allele carriers was reported recently.
E28 IL6 polymorphisms have also been associated with lung function decrease and chronic obstructive pulmonary disease (COPD). One study found an association between the IL6 2572G/C (rs1800796) polymorphism and COPD. E38 In the same study the 2174 (rs1800795) and 2597 (rs1800797) SNPs were not associated with COPD, but the haplotype containing a G allele of both of these SNPs was found to be protective of it. E38 Another study reported association of the rs1800795 and rs1800797 C and A alleles, respectively, with a rapid decrease in FEV 1 and an increased risk of COPD. E39 A recent meta-analysis found that rs1800796 associates with COPD but rs1800797 does not. NA, Not applicable; SHS, second-hand smoke exposure. *Education missing for 17 asthmatic patients and 41 control subjects in the CIAS study. Smoking missing for 2 asthmatic patients and 1 control subject in FEAS and for 5 asthmatic patients and 11 control subjects in the CIAS study. àCigarette years missing for 13 cases and 15 control subjects in the FEAS and for 29 cases and 106 control subjects in the CIAS study. §Lifetime cumulative SHS exposure missing for 20 asthmatic patients and 24 control subjects in FEAS. , variation in estimate attributable because of heterogeneity. *P value for heterogeneity in meta-analyses.
E40
Adjusted for age, sex, and education in FEAS and for age and education in the CIAS study. àEducation missing for 17 asthmatic patients and 41 control subjects in the CIAS study. In the CIAS study a separate category for missing education was included in the analyses. §Genotyping of rs1800797 in FEAS is missing for 2 cases and 3 control subjects, and genotyping of rs1800795 in the CIAS study is missing for 1 case and 2 control subjects. kSmoking missing for 2 asthmatic patients and 1 control subject in FEAS and for 5 asthmatic patients and 11 control subjects in the CIAS study. {In the CIAS study adjustment could not be carried out for the 3-category education, and thus a 2-category education (comprehensive schooling or vocational course/institution vs high school) was applied instead. Boldface indicates statistical significance. NA, Not applicable; OR, odds ratio. *Adjusted for age and education. Education missing for 17 asthmatic patients and 41 control subjects in the CIAS study; a separate category for missing education was included in the analyses. àSmoking missing for 5 asthmatic patients and 11 control subjects in the CIAS study. 
